Bolleurs Pepijn B, Jonker Brend P, Elbers Joris Bw, Verduijn Gerda M, Gül Atilla, Sewnaik Aniel, Heemsbergen Wilma D
Department of Radiotherapy, Erasmus MC Cancer Institute, University Medical Center Rotterdam, Rotterdam, the Netherlands.
Erasmus University College, Rotterdam, the Netherlands.
Clin Transl Radiat Oncol. 2025 May 30;53:100988. doi: 10.1016/j.ctro.2025.100988. eCollection 2025 Jul.
We evaluated locoregional failure (LRF) and survival after postoperative radiotherapy (PORT) in selected high-risk oral squamous cell carcinoma (OSCC) patients.
In a retrospective OSCC cohort (n = 219) treated with local (n = 216) and/or regional (n = 87) PORT in 2011-2018, we determined the first location of tumor recurrence or progression, survival, and cause of death. Tumor control and survival was calculated using Kaplan Meier method. Prognostic factors were evaluated in Cox regression models.
Main subsites were oral tongue (34 %), gingiva (32 %), and floor of mouth (27 %). Eight percent also received chemotherapy. Median follow-up was five year for tumor control and eight year for survival. Tumor progression was observed in 47 patients (n = 31 LRF). Nine patients had salvage treatment. Locoregional control was 87 % and 84 % at 2 and 5 years, respectively. Significant prognostic factors for local failure (LF) were T4 stage, bone invasion, and subsite gingiva; 12 of 18 LF concerned a T4 gingiva tumor with bone invasion. For regional failure (RF), pN1 (vs pN0) was prognostic, mainly concerning solitary contralateral RFs. Overall survival was 63 % and 48 % at 5 and 8 year, respectively. Main causes of death (104 events) were the index tumor (n = 42) and a post-treatment second primary tumor (n = 37).
A locoregional control of 84 % was achieved after PORT for high-risk OSCC with only 8 % receiving additional chemotherapy. Overall survival was 48 % at 8 years, with a large proportion of cancer-related deaths related to the index tumor and other subsequent tumor diagnoses. Risk of LF was increased for gingiva tumors with bone invasion. N1 stage was associated with a risk of solitary contralateral RFs in non-irradiated neck areas.
我们评估了部分高危口腔鳞状细胞癌(OSCC)患者术后放疗(PORT)后的局部区域失败(LRF)情况及生存率。
在一个2011年至2018年接受局部(n = 216)和/或区域(n = 87)PORT治疗的回顾性OSCC队列(n = 219)中,我们确定了肿瘤复发或进展的首个部位、生存率及死亡原因。使用Kaplan Meier方法计算肿瘤控制率和生存率。在Cox回归模型中评估预后因素。
主要亚部位为舌(34%)、牙龈(32%)和口底(27%)。8%的患者还接受了化疗。肿瘤控制的中位随访时间为5年,生存的中位随访时间为8年。47例患者出现肿瘤进展(n = 31例LRF)。9例患者接受了挽救性治疗。2年和5年时的局部区域控制率分别为87%和84%。局部失败(LF)的显著预后因素为T4期、骨侵犯和牙龈亚部位;18例LF中有12例涉及伴有骨侵犯的T4牙龈肿瘤。对于区域失败(RF),pN1(相对于pN0)具有预后意义,主要涉及孤立的对侧RF。5年和8年时的总生存率分别为63%和48%。主要死亡原因(104例事件)为原发肿瘤(n = 42)和治疗后出现的第二原发性肿瘤(n = 37)。
高危OSCC患者PORT后局部区域控制率达84%,仅8%的患者接受了额外化疗。8年时总生存率为48%,很大一部分癌症相关死亡与原发肿瘤及其他后续肿瘤诊断有关。伴有骨侵犯的牙龈肿瘤LF风险增加。N1期与未照射颈部区域孤立的对侧RF风险相关。